Skip to content
Study details
Enrolling now

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

University of Rochester
NCT IDNCT06956781ClinicalTrials.gov data as of Apr 2026
Target enrollment

200

Study length

about 2.6 years

Ages

8–17

Locations

1 site in NY

About this study

Researchers are testing different treatment components to improve pediatric post-traumatic stress disorder (PTSD). The trial will also provide evidence on how these components work. Researchers will compare the components to a psychological placebo and examine their effects alone and in combination with other components.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Bi-lateral Stimulation
  • 2.Participate in Cognitive Processing
  • 3.Participate in Emotion Regulation
  • +2 more
Primary goalMean Change in PTSD Symptoms - Child PTSD Symptom Scale for DSM-5 (CPSS)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low3%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Mean Change in PTSD Symptoms - Child PTSD Symptom Scale for DSM-5 (CPSS), Mean Change in PTSD Symptoms - Child and Adolescent Trauma Screen (CATS-2), Mean Change in PTSD Symptoms - Clinician Administered PTSD Scale for DSM-5 - Child/Adolescent Version (CAPS-CA)

Secondary: Brain Aging - Magnetic Resonance Imaging (MRI), Change in Network Connectivity - Magnetic Resonance Imaging (MRI), Change in Neural Structure - Magnetic Resonance Imaging (MRI), Change in PTSD Symptom Trajectories - Child PTSD Symptom Scale for DSM-5 (CPSS), Change in PTSD Symptom Trajectories - Child and Adolescent Trauma Screen (CATS-2), Change in PTSD, Mood, Anxiety, and Disruptive Behavior Disorder Symptom Trajectories - Ecological Momentary Assessment (EMA), Changes in Trajectories of C-Reactive Protein (CRP), Changes in Trajectories of Interleukin-6 (IL-6)

Procedures

therapy

Body systems

Psychiatry / Mental Health, Oncology